Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
modified Yin Qiao San (Guangdong Provincial Hospital of Traditional Chinese Medicine)
- Development stage
- Unknown
- Lead developer
- The Second Affiliated Hospital of Guangzhou University of Chinese Medicine
- Administration
- Oral
01
Overview
Modified Yin Qiao San is a Traditional Chinese Medicine (TCM) herbal formula based on the classic Yin Qiao San prescription, which has been used for centuries to treat wind-heat type respiratory ailments. This specific modification is developed by the Second Affiliated Hospital of Guangzhou University of Chinese Medicine for the treatment of COVID-19. The formula typically consists of a combination of herbs including *Lonicera japonica* (honeysuckle) and *Forsythia suspensa*, which are believed to possess antiviral and anti-inflammatory properties. In clinical trials, it is often used as an adjunct to conventional Western medicine to reduce symptom duration and prevent progression to severe disease by modulating the immune response and inhibiting inflammatory cytokine production.
- Other names
- Yinqiaosan Modified FormulaModified Yinqiao PowderJiajian Yinqiao San
02
Targets
Mpro (3C-like proteinase of SARS-CoV-2)TNFA (Tumor necrosis factor alpha (soluble))IL-6R (Interleukin-6 receptor subunit alpha)
Beyond the preview
Go deeper on modified Yin Qiao San (Guangdong Provincial Hospital of Traditional Chinese Medicine).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on modified Yin Qiao San (Guangdong Provincial Hospital of Traditional Chinese Medicine).